Search

Search Constraints

You searched for: Author/Creator Simon, Matthias

Search Results

1. A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. Issue 4 (March 2015)

2. A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. Issue 4 (March 2015)

3. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Issue 10 (19th November 2013)

5. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Issue 5 (May 2017)

6. Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma. (November 2020)

7. Functional characterization of an oxytocin receptor gene variant (rs2268498) previously associated with social cognition by expression analysis in vitro and in human brain biopsy. (3rd September 2017)

9. Genome-wide association analysis identifies a meningioma risk locus at 11p15.5. Issue 11 (12th May 2018)

10. Genome-wide association study of sporadic brain arteriovenous malformations. Issue 9 (27th January 2016)